Impact of a Community-Based Weight Loss Program on Renal Function.
| Autor: | Schwasinger-Schmidt TE; Internal Medicine, Kansas University School of Medicine-Wichita, Wichita, USA., Elhomsy G; Internal Medicine, Kansas University School of Medicine-Wichita, Wichita, USA., Paull-Forney BG; Weight Management Clinic, Ascension Via Christi Hospitals, Wichita, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2020 May 13; Vol. 12 (5), pp. e8101. Date of Electronic Publication: 2020 May 13. |
| DOI: | 10.7759/cureus.8101 |
| Abstrakt: | Introduction Obesity is associated with increased morbidity and mortality and is an independent risk factor for the development and progression of chronic kidney disease (CKD). This study investigated the effect of a community-based, lifestyle-focused, weight-loss intervention on renal function among participants at baseline following 12 weeks of therapy. Methods A retrospective analysis of adults enrolled in a weight management program from 2009 to 2014 was conducted. Participants consumed at least 800 kilocalories per day in meal replacements, attended weekly behavioral education classes, and expended approximately 300 kilocalories per day in physical activity. The primary outcome was the association of weight loss and changes in glomerular filtration rate (GFR). Secondary outcomes included changes in blood sugar levels, lipid parameters, blood pressure, and the use of medication for hypertension and diabetes mellitus. Results Of the 71 participants, 63.4% were female, the average weight was 289 pounds, the average body mass index (BMI) of 53, and baseline GFR 47 ml/min/1.73m 2 . Following 12 weeks of the intervention, 76.1% of participants improved in CKD stage, 22.4% remained within the same stage, and 1.5% progressed to a higher stage (3A to 3B). Analysis revealed a correlation between weight loss and improved GFR (p=0.0006). Improvements were noted in blood sugar levels, blood pressure, and lipids (p<0.05). Medications were reduced in 61.8% of participants for hypertension and 83.3% for diabetes. Conclusions A significant correlation was observed between weight loss and improved renal function, with most participants improving in CKD stage. Participants also improved in markers of chronic disease and required fewer medications. When controlling for both diabetes and hypertension, the effect of improved renal function persisted. Competing Interests: The authors have declared financial relationships, which are detailed in the next section. (Copyright © 2020, Schwasinger-Schmidt et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|